Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Federman & Sherwood has launched an investigation into allegations that CVS Caremark misled Oklahoma residents concerning prescription policies. Reports indicate that CVS informed customers that it could only fill 30-day prescriptions due to state law, and that its mail-order pharmacy could not operate in Oklahoma. However, state lawmakers claim these statements are false. Following a settlement with the Oklahoma Insurance Commissioner, CVS was required to clarify that long-term prescription refills were not outlawed, but instead, CVS's communications allegedly spread further misinformation.